Skip to search formSkip to main contentSkip to account menu

beclobrate

Known as: 2-(4-((4-chlorophenyl)methyl)phenoxy)-2-methylbutanoic acid ethyl ester, Butanoic acid, 2-(4-((4-chlorophenyl)methyl)phenoxy)-2-methyl-, ethyl ester, (+-)- 
A structural analog of clofibrate, converted to its free acid form after oral administration. Beclobrate reduces LDL-cholesterol and increased HDL… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Benzhydryl CompoundsHypolipidemic Agents

Narrower (1)

Sgd 24774

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Beclobrate and liver disease.
To the Editors: A 63-year-old woman died from acute liver failure while being treated with beclobrate, a lipid lowering agent… 
1990
1990
Beclobrate : a new lipoprotein regulator
1988
1988
[Long-term therapy of type II and type IV hyperlipoproteinemia using beclobrate].
1985
1985
[Metabolism of beclobrate in rat and man].
The major pathway of biotransformation of beclobrate [(2-[4-[(4-chlorophenyl)methyl]phenoxy]-2-methylbutyric acid ethyl ester] is… 
1983
1983
Pharmacological studies with beclobrate, a new hypolipidemic agent.
A new diphenylmethane derivative with potent hypolipidemic activity, ethyl-(+/-)-2-[[alpha-(p-chlorophenyl)-p-tolyl]-oxy]-2… 
1983
1983
Influence of beclobrate on gallstone formation in hamsters.
Three groups of male Syrian hamsters were fed a lithogenic diet (L), L plus 0.04% ethyl-2-[4-(p-chlorophenyl) methylphenoxy]-2… 
1983
1983
Influence of beclobrate and eniclobrate on cholesterol metabolism in rats.
Two new hypocholesterolemic compounds, ethyl-(+/-)-2-[[alpha-(p-chlorophenyl)-p-tolyl]-oxy]-2-methylbutyrate (Sgd 24 774… 
1981
1981
Lipid-lowering effect of the new drugs eniclobrate and beclobrate in patients with hyperlipidemia type II a and type II b.
First clinical results are presented for two newly developed drugs. Both are diphenylmethane derivatives named ethyl-(+/-)-2…